Regeneron Pharma (REGN) Posts Q1 Loss of $0.49, Wider than Views
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $803.90 --0%
EPS Growth %: +35.2%
Financial Fact:
Net product sales: 857.47M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +35.2%
Financial Fact:
Net product sales: 857.47M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q1 loss of ($0.49), $0.13 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $112.2 million versus the consensus estimate of $117.02 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- Radiant Logistics (RLGT) Tops Q4 EPS by 9c
- General Mills beats estimates as cost savings offset volumes
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
